Schedule
-
Different Roles, One Mission: Inspiring Care in Pediatric Oncology Nursing
Thursday, November 06 8:30 AM - 10:00 AM
Speaker(s)
-
Pain App for Adolescents
Thursday, November 06 10:50 AM - 11:20 AM
Speaker(s)
-
CAR T and BMT - Why, When, and How
Thursday, November 06 11:50 AM - 12:35 PM
Speaker(s)
-
Infections in the Immunocompromised Patient
Thursday, November 06 1:35 PM - 2:20 PM
Speaker(s)
Using real-world case vignettes, this session will highlight key aspects of diagnosing and managing infections in children undergoing cancer treatment. Attendees will explore practical approaches to bacterial, viral, fungal, and parasitic infections, with a focus on evidence-based strategies and clinical decision-making.
-
Between a Pump and a Painful Place: Nursing Considerations in the Administration of Dinutuximab and Blinatumomab Infusions.
Thursday, November 06 2:20 PM - 3:05 PM
Speaker(s)
-
Quick Hits - The ABC's of POGO Satellite Clinics
Thursday, November 06 3:05 PM - 3:25 PM
Speaker(s)
-
Quick Hits - QI Wellness Cart
Thursday, November 06 3:45 PM - 4:05 PM
Speaker(s)
-
The Heart of Healing: Challenges and Triumphs of Patient-Reported Outcomes
Thursday, November 06 4:35 PM - 5:25 PM
Speaker(s)
This presentation explores the opportunities and obstacles in embedding patient-reported outcomes into pediatric cancer research and clinical care. Drawing on real-world experiences, we will highlight how children’s and families’ voices can guide meaningful improvements in treatment, quality of life, and care delivery.
The session will emphasize both the aspirations and the actionable steps needed to place the patient voice at the center of healing.
-
Contemporary ALL therapy: Where did it come from? Where will it go?
Friday, November 07 8:45 AM - 9:30 AM
Speaker(s)
Sixty years ago, a diagnosis of acute lymphoblastic leukemia (ALL) was a considered an incurable disease. Thanks to cytotoxic chemotherapy, cure rates have soared to 85%—a remarkable achievement, but one that has plateaued. Now, groundbreaking advances in immunotherapy are pushing the boundaries even further. This session explores how these innovations are not only improving survival rates but also transforming the treatment landscape to minimize both short- and long-term toxicities. Join us to discover how the next generation of ALL therapy is being defined today.
-
Navigating the Dilemmas: Challenging ALL Cases
Friday, November 07 9:30 AM - 10:30 AM
Speaker(s)Moderator(s)
Acute lymphoblastic leukemia (ALL) presents a wide spectrum of clinical challenges, especially in complex or atypical cases. This dynamic session will have leading ALL experts from across North America delving into the nuances of diagnosing and managing difficult ALL scenarios. Through an interactive review of real-world cases, participants will explore diverse presentations, diagnostic dilemmas, and evolving treatment strategies. Whether you're refining your clinical approach or seeking insights into emerging therapies, this session offers a valuable opportunity to enhance your decision-making in the face of ALL’s toughest dilemmas.
-
Session A: Building an AYA Program
Friday, November 07 10:45 AM - 11:45 AM
Speaker(s)
-
Session B: How to start a QI project
Friday, November 07 10:45 AM - 11:45 AM
Speaker(s)
-
Session C: PWLE Panel - Through the Eyes of a Family: Supporting and Empowering Families in Pediatric Cancer Care
Friday, November 07 10:45 AM - 11:45 AM
Speaker(s)
What is it like to be a family navigating pediatric cancer, where life-changing decisions are often made without your input? In this heartfelt session, childhood cancer survivor Oliver Acosta-Pickering and his mother, Dawn Pickering, share their powerful journey and advocate for a more inclusive, family-centered approach to care. Through their lived experience, they emphasize the importance of asking both children and parents how they feel, what they need, and recognizing their ability to contribute meaningfully to care decisions. Their story offers valuable insights into how listening, empathy, and empowerment can transform the treatment experience for young patients and their families.This session will inspire healthcare professionals and educators to strengthen psychosocial support, foster trust and dignity, and elevate the voices of young patients and their families, ultimately transforming the treatment experience for children and families alike. -
Session D: Mission Possible: Navigating Challenges in Pediatric Oncology End of Life Care
Friday, November 07 10:45 AM - 11:45 AM
Speaker(s)
Sixty years ago, a diagnosis of acute lymphoblastic leukemia (ALL) was a considered an incurable disease. Thanks to cytotoxic chemotherapy, cure rates have soared to 85%—a remarkable achievement, but one that has plateaued. Now, groundbreaking advances in immunotherapy are pushing the boundaries even further. This session explores how these innovations are not only improving survival rates but also transforming the treatment landscape to minimize both short- and long-term toxicities. Join us to discover how the next generation of ALL therapy is being defined today.
-
Immunization in Pediatric Oncology: What’s New In Ontario
Friday, November 07 11:45 AM - 12:15 PM
Speaker(s)
Children undergoing and following cancer treatment face unique challenges in maintaining immunity against vaccine-preventable diseases. This session will highlight recent developments in pediatric immunization protocols during and after cancer therapy.
-
Bridging Promise and Practice: Advancing Blinatumomab Care for Children with Leukemia
Friday, November 07 1:30 PM - 2:15 PM
Speaker(s)
This presentation explores the urgent need to strengthen care delivery for children receiving blinatumomab, drawing on caregiver experiences and clinical insights. We will highlight both the promise of improved outcomes, and the real-world challenges families face in managing complex at-home infusions. Key next steps for research, education, and system-level support will be outlined to ensure equitable, high-quality care across pediatric oncology settings.
-
CNS Embryonal Tumours in Very Young Children
Friday, November 07 2:15 PM - 3:00 PM
Speaker(s)
This session offers a comprehensive overview of the current landscape of central nervous system (CNS) embryonal brain tumors (EBTs) in young children, highlighting both historical and ongoing therapeutic challenges. Attendees will gain insight into the evolution of treatment approaches and the complexities that continue to shape clinical decision-making today. The session will also introduce “DECRYPT Babybrain”, a Canadian-led clinical trial designed to address key gaps in care and improve outcomes for this vulnerable population. Join us for a forward-looking discussion on innovation, collaboration, and the future of pediatric neuro-oncology.
-
Care for the Caregiver
Friday, November 07 3:30 PM - 4:30 PM
Speaker(s)Moderator(s)
-
Supporting Children and Youth with Procedures Using Trauma Informed Principles
Saturday, November 08 8:20 AM - 9:10 AM
Speaker(s)
Hospitalization and cancer treatment can be deeply distressing experiences for children and youth. This collaborative session explores how trauma-informed principles can be applied in pediatric care to recognize, prevent, and respond to potentially traumatic medical events. Attendees will gain actionable strategies and interventions designed to support emotional safety and resilience in young patients—empowering healthcare professionals and educators to make a meaningful difference during some of life’s most challenging moments.
-
Session A: Building an AYA Program
Saturday, November 08 9:20 AM - 10:20 AM
Speaker(s)
-
Session B: How to start a QI project
Saturday, November 08 9:20 AM - 10:20 AM
Speaker(s)
-
Session C: Career Advice for YI/Fellow
Saturday, November 08 9:20 AM - 10:20 AM
Speaker(s)
-
Session D: Mission Possible: Navigating Challenges in Pediatric Oncology End of Life Care
Saturday, November 08 9:20 AM - 10:20 AM
Speaker(s)
Caring for children with cancer at the end of life presents profound emotional and clinical challenges for multidisciplinary teams. This interactive session uses a compelling case study and elements of serious games to explore the complexities of collaborative decision-making and compassionate care. Participants will gain deeper insight into team dynamics and walk away with practical strategies to support patients, families, and each other during the most critical moments of care.
-
Wilms Tumor: The ERAs Tour
Saturday, November 08 10:40 AM - 11:40 AM
Speaker(s)
Inspired by the format of Taylor Swift’s iconic ERAs Tour, this dynamic and creative session takes attendees on a journey through the evolution of Wilms Tumor care—from its initial discovery to groundbreaking treatments and the development of clinical trials that have dramatically improved patient outcomes. Each "ERA" highlights key milestones in research and care, brought to life with embedded audio clips that enhance engagement and reinforce learning. This session promises to be both informative and entertaining, offering a fresh perspective on the history and future of Wilms Tumor treatment.
Date
November 6-8, 2025
Location
Blue Mountain
156 Jozo Weider Blvd,
The Blue Mountains, ON
Rates
Early Bird (end Sept 30) | |
---|---|
Symposium | $350 |
Pre-Symposium Nursing Day | $125 |
Bundle: Pre-Symposium Nursing Day & Symposium | $450 |
Regular Rate | |
Symposium | $450 |
Pre-Symposium Nursing Day | $150 |
Bundle: Pre-Symposium Nursing Day & Symposium | $500 |
Fellow and Student Rate | |
Symposium | $175 |
Pre-Symposium Nursing Day | $50 |
Bundle: Pre-Symposium Nursing Day & Symposium | $200 |